Most patients with chronic granulomatous disease (CGD) have mutations in the X-linked CYBB gene that encodes gp91 phox , a component of the phagocyte NADPH oxidase. The resulting X-linked form of CGD is usually manifested in boys. Rarely, X-CGD is encountered in female carriers with extreme expression of the mutated gene. Here, we report on a woman with a novel mutation in CYBB (CCG [90][91][92] 3 GGT), predicting Tyr30Arg31 3 stop, Val in gp91 phox , who presented with clinical symptoms at the age of 66. The mutation was present in heterozygous form in genomic DNA from her leukocytes but was fully expressed in mRNA from these cells, indicating that in her leukocytes the X chromosome carrying the nonmutated CYBB allele had been inactivated. Indeed, only 0.4% to 2% of her neutrophils showed NADPH oxidase activity. This extreme skewing of her Xchromosome inactivation was not found in her cheek mucosal cells and is thus not due to a general defect in gene methylation on one X chromosome. Moreover, the CYBB mutation was not present in the DNA from her cheek cells and was barely detectable in the DNA from her memory T lymphocytes. Thus, this patient shows a somatic mosaic for the CYBB mutation, which probably originated during her lifetime in her bone marrow.
IntroductionChronic granulomatous disease (CGD) is a rare, heterogeneous, inherited disorder that affects about 1 in 250 000 individuals. 1,2 The main defect in CGD is a failure of neutrophils, monocytes, macrophages, and eosinophils to mount a respiratory burst and, therefore, to generate superoxide anions and other reactive oxygen species derived from superoxide, such as hydrogen peroxide. This renders the patients susceptible to severe, recurrent bacterial and fungal infections. [3][4][5] The enzyme that generates superoxide is a phagocyte-specific nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, consisting of 2 membrane-bound subunits and 4 cytosolic proteins involved in activity regulation of the enzyme. 1,2 The central, catalytic subunit is gp91 phox , a flavocytochrome that forms a heterodimer with p22 phox in the plasma membrane of phagocytic leukocytes. Defects in gp91 phox are inherited in an X-linked fashion because its gene, CYBB, is located on the X chromosome. About 70% to 75% of the CGD patients are X-CGD patients. 1,2,6 Autosomal forms of CGD are due to mutations in CYBA, the gene that encodes p22 phox in approximately 3% of the CGD patients 6,7 or to mutations in the genes encoding the cytosolic proteins p47 phox (ϳ 25%) or p67 phox (ϳ 3%). 1,2,6 For many years the onset of CGD was regarded to occur early in infancy, with fatal outcome in adolescence, due to the recurrent severe infections and the secondary granulomatous and fibrotic tissue formation that develops in many organs. Changes frequently occur in the skin, lymph nodes, and lungs, but also in bones, joints, liver, and kidneys, leading eventually to pulmonary, gastrointestinal, musculoskeletal, and renal insufficiency. 1,2,5,8,9 In the last decades, with the rapid developme...